Free webinar: Novel outpatient COVID treatments

FOUND IN: Clinical Event, Events

Date

Monday, January 24, 2022

Time

12:00pm - 1:00pm

Location

https://ww2.highmarksce.com/micme/index.cfm?do=pln.viewActivity&style=2&preview=true&plannerID=4961

Description

Previously, monoclonal antibodies (mAb) have been the primary outpatient treatment for high-risk individuals with COVID-19 to reduce hospitalization and severe illness, in addition to vaccines. Only one monoclonal antibody, sotrovimab, is effective against the omicron variant currently circulating, resulting in a shortage of treatments. Fortunately, there are now new promising antiviral treatments including ritonavir boosted nirmatrelvir (Paxlovid) and molnupiravir. However, providers are unfamiliar with these medications, including how to manage drug-drug interactions with Paxlovid and the process for prescribing these medications, which are in short supply. Participants will increase prescribing these novel medications/treatments.

https://ww2.highmarksce.com/micme/index.cfm?do=pln.viewActivity&style=2&preview=true&plannerID=4961

RELATED STORIES